Skip to main content
Erschienen in: Pituitary 3/2013

01.09.2013

Enhanced nestin expression and small blood vessels in human pituitary adenomas

verfasst von: María Inés Perez-Millan, Silvia Inés Berner, Guillermina María Luque, Cristian De Bonis, Gustavo Sevlever, Damasia Becu-Villalobos, Carolina Cristina

Erschienen in: Pituitary | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

The role of angiogenesis in human pituitary tumor progression is questioned. Our aim was to characterize the morphologic changes that occur in the vasculature of pituitary adenomas, in correlation with the expression of nestin, a protein found in endothelial cells of newly formed vessels of developing organs. We also evaluated the relation of angiogenic markers and nestin with Ki-67 index. Immunohistochemical studies were performed on paraffin embedded samples of 47 pituitary adenomas and six normal pituitaries. We determined microvessel density (number of CD31+ or CD34+ vessels per square millimetre), vascular area (cumulative area occupied by vessels), average vessel size, and further classified vessels as small (<100 μm2) or large (>100 μm2). We correlated the above parameters with nestin expression and Ki-67 index. Lower vascular area compared to normal tissue was found in adenomas (p < 0.05). Interestingly, pituitary adenomas had significantly more small vessels than control pituitaries (p < 0.04 for CD31 and CD34). In tumors many capillaries were positive for nestin, while scarce staining was detected in controls, so that nestin positive area was significantly higher in tumors. Furthermore, nestin area correlated positively with the % of small vessels. Ki-67 correlated neither with vascular area nor with nestin expression. In human pituitary tumors there was a predominance of small capillaries in correlation with increased expression of the progenitor marker nestin. We suggest that angiogenesis is an active process in these tumors, in spite of their low total vascular area when compared to normal pituitaries.
Literatur
1.
2.
Zurück zum Zitat Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6CrossRefPubMed Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6CrossRefPubMed
3.
Zurück zum Zitat Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG, Nichols PW (1995) Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 87:1603–1612CrossRefPubMed Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG, Nichols PW (1995) Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 87:1603–1612CrossRefPubMed
4.
Zurück zum Zitat Weidner N, Semple J, Welch W, Folkman J (1991) Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med 324:1–8CrossRefPubMed Weidner N, Semple J, Welch W, Folkman J (1991) Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med 324:1–8CrossRefPubMed
5.
Zurück zum Zitat Weidner N (1996) Intratumoral vascularity as a prognostic factor in cancers of the urogenital tract. Eur J Cancer 32A:2506–2512CrossRefPubMed Weidner N (1996) Intratumoral vascularity as a prognostic factor in cancers of the urogenital tract. Eur J Cancer 32A:2506–2512CrossRefPubMed
6.
Zurück zum Zitat Turner HE, Harris AL, Melmed S, Wass JA (2003) Angiogenesis in endocrine tumors. Endocr Rev 24:600–632CrossRefPubMed Turner HE, Harris AL, Melmed S, Wass JA (2003) Angiogenesis in endocrine tumors. Endocr Rev 24:600–632CrossRefPubMed
7.
Zurück zum Zitat Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW (1995) Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: a quantitative morphologic study. Endocr Pathol 6:115–124CrossRefPubMed Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW (1995) Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: a quantitative morphologic study. Endocr Pathol 6:115–124CrossRefPubMed
8.
Zurück zum Zitat Toi M, Inada K, Suzuki H, Tominaga T (1995) Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36:193–204CrossRefPubMed Toi M, Inada K, Suzuki H, Tominaga T (1995) Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36:193–204CrossRefPubMed
9.
Zurück zum Zitat Vermeulen PB, Dirix LY, Van Marck E, Van Oosterom AT (1996) High endothelial cell proliferation index and high microvessel density in vascular hotspots suggest an active angiogenic process in human colorectal adenocarcinomas. Angiogenesis Group. Br J Cancer 74:1506–1507CrossRefPubMed Vermeulen PB, Dirix LY, Van Marck E, Van Oosterom AT (1996) High endothelial cell proliferation index and high microvessel density in vascular hotspots suggest an active angiogenic process in human colorectal adenocarcinomas. Angiogenesis Group. Br J Cancer 74:1506–1507CrossRefPubMed
10.
Zurück zum Zitat Mokry J, Ehrmann J, Karbanova J, Cizkova D, Soukup T, Suchanek J, Filip S, Kolar Z (2008) Expression of intermediate filament nestin in blood vessels of neural and non-neural tissues. Acta Medica (Hradec Kralove) 51:173–179 Mokry J, Ehrmann J, Karbanova J, Cizkova D, Soukup T, Suchanek J, Filip S, Kolar Z (2008) Expression of intermediate filament nestin in blood vessels of neural and non-neural tissues. Acta Medica (Hradec Kralove) 51:173–179
11.
Zurück zum Zitat Gautron L, De Smedt V, Laye S (2009) Age-related changes in nestin immunoreactivity in the rat pituitary gland. Neuroendocrinology 90:19–30CrossRefPubMed Gautron L, De Smedt V, Laye S (2009) Age-related changes in nestin immunoreactivity in the rat pituitary gland. Neuroendocrinology 90:19–30CrossRefPubMed
12.
Zurück zum Zitat Rotondo F, Kovacs K, Horvath E, Bell CD, Lloyd RV, Scheithauer BW (2006) Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms. Acta Neuropathol 111:272–277CrossRefPubMed Rotondo F, Kovacs K, Horvath E, Bell CD, Lloyd RV, Scheithauer BW (2006) Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms. Acta Neuropathol 111:272–277CrossRefPubMed
13.
14.
Zurück zum Zitat Cristina C, Diaz-Torga G, Baldi A, Gongora A, Rubinstein M, Low MJ, Becu-Villalobos D (2005) Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice. Endocrinology 146:2952–2962CrossRefPubMed Cristina C, Diaz-Torga G, Baldi A, Gongora A, Rubinstein M, Low MJ, Becu-Villalobos D (2005) Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice. Endocrinology 146:2952–2962CrossRefPubMed
15.
Zurück zum Zitat Cristina C, Diaz-Torga G, Gongora A, Guida MC, Perez-Millan MI, Baldi A, Becu-Villalobos D (2007) Fibroblast growth factor-2 in hyperplastic pituitaries of D2R knockout female mice. Am J Physiol Endocrinol Metab 293:E1341–E1351CrossRefPubMed Cristina C, Diaz-Torga G, Gongora A, Guida MC, Perez-Millan MI, Baldi A, Becu-Villalobos D (2007) Fibroblast growth factor-2 in hyperplastic pituitaries of D2R knockout female mice. Am J Physiol Endocrinol Metab 293:E1341–E1351CrossRefPubMed
16.
Zurück zum Zitat Nico B, Benagiano V, Mangieri D, Maruotti N, Vacca A, Ribatti D (2008) Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol 23:601–607PubMed Nico B, Benagiano V, Mangieri D, Maruotti N, Vacca A, Ribatti D (2008) Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol 23:601–607PubMed
17.
Zurück zum Zitat Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, Onoda N, Kato Y, Nitta A, Arimoto Y et al (1995) Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13:477–481PubMed Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, Onoda N, Kato Y, Nitta A, Arimoto Y et al (1995) Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13:477–481PubMed
18.
Zurück zum Zitat Di Ieva A, Grizzi F, Gaetani P, Goglia U, Tschabitscher M, Mortini P, Baena R (2008) Euclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue. Neurosurg Rev 31:271–281CrossRefPubMed Di Ieva A, Grizzi F, Gaetani P, Goglia U, Tschabitscher M, Mortini P, Baena R (2008) Euclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue. Neurosurg Rev 31:271–281CrossRefPubMed
19.
Zurück zum Zitat Schechter J (1972) Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol 67:109–126PubMed Schechter J (1972) Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol 67:109–126PubMed
20.
Zurück zum Zitat Smith-McCune KK, Weidner N (1994) Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 54:800–804PubMed Smith-McCune KK, Weidner N (1994) Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 54:800–804PubMed
21.
Zurück zum Zitat Brem SS, Jensen HM, Gullino PM (1978) Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 41:239–244CrossRefPubMed Brem SS, Jensen HM, Gullino PM (1978) Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 41:239–244CrossRefPubMed
22.
Zurück zum Zitat Poncelet C, Madelenat P, Feldmann G, Walker F, Darai E (2002) Expression of von Willebrand’s factor, CD34, CD31, and vascular endothelial growth factor in uterine leiomyomas. Fertil Steril 78:581–586CrossRefPubMed Poncelet C, Madelenat P, Feldmann G, Walker F, Darai E (2002) Expression of von Willebrand’s factor, CD34, CD31, and vascular endothelial growth factor in uterine leiomyomas. Fertil Steril 78:581–586CrossRefPubMed
23.
Zurück zum Zitat de la Torre NG, Buley I, Wass JA, Turner HE (2006) Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour. Endocr Relat Cancer 13:931–944CrossRefPubMed de la Torre NG, Buley I, Wass JA, Turner HE (2006) Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour. Endocr Relat Cancer 13:931–944CrossRefPubMed
24.
Zurück zum Zitat Jasek E, Furgal-Borzych A, Lis GJ, Litwin JA, Rzepecka-Wozniak E, Trela F (2009) Microvessel density and area in pituitary microadenomas. Endocr Pathol 20:221–226CrossRefPubMed Jasek E, Furgal-Borzych A, Lis GJ, Litwin JA, Rzepecka-Wozniak E, Trela F (2009) Microvessel density and area in pituitary microadenomas. Endocr Pathol 20:221–226CrossRefPubMed
25.
Zurück zum Zitat Itoh J, Serizawa A, Kawai K, Ishii Y, Teramoto A, Osamura RY (2003) Vascular networks and endothelial cells in the rat experimental pituitary glands and in the human pituitary adenomas. Microsc Res Tech 60:231–235CrossRefPubMed Itoh J, Serizawa A, Kawai K, Ishii Y, Teramoto A, Osamura RY (2003) Vascular networks and endothelial cells in the rat experimental pituitary glands and in the human pituitary adenomas. Microsc Res Tech 60:231–235CrossRefPubMed
26.
Zurück zum Zitat Cristina C, Perez-Millan MI, Luque G, Dulce RA, Sevlever G, Berner SI, Becu-Villalobos D (2010) VEGF and CD31 association in pituitary adenomas. Endocr Pathol 21:154–160CrossRefPubMed Cristina C, Perez-Millan MI, Luque G, Dulce RA, Sevlever G, Berner SI, Becu-Villalobos D (2010) VEGF and CD31 association in pituitary adenomas. Endocr Pathol 21:154–160CrossRefPubMed
27.
Zurück zum Zitat Luque GM, Perez-Millan MI, Ornstein AM, Cristina C, Becu-Villalobos D (2011) Inhibitory effects of anti-VEGF strategies in experimental dopamine resistant prolactinomas. J Pharmacol Exp Ther 337:766–774 Luque GM, Perez-Millan MI, Ornstein AM, Cristina C, Becu-Villalobos D (2011) Inhibitory effects of anti-VEGF strategies in experimental dopamine resistant prolactinomas. J Pharmacol Exp Ther 337:766–774
28.
Zurück zum Zitat Lendahl U, Zimmerman LB, McKay RD (1990) CNS stem cells express a new class of intermediate filament protein. Cell 60:585–595CrossRefPubMed Lendahl U, Zimmerman LB, McKay RD (1990) CNS stem cells express a new class of intermediate filament protein. Cell 60:585–595CrossRefPubMed
29.
Zurück zum Zitat Veselska R, Kuglik P, Cejpek P, Svachova H, Neradil J, Loja T, Relichova J (2006) Nestin expression in the cell lines derived from glioblastoma multiforme. BMC Cancer 6:32CrossRefPubMed Veselska R, Kuglik P, Cejpek P, Svachova H, Neradil J, Loja T, Relichova J (2006) Nestin expression in the cell lines derived from glioblastoma multiforme. BMC Cancer 6:32CrossRefPubMed
30.
Zurück zum Zitat Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA (2009) Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer. Cancer Res 69:4708–4715CrossRefPubMed Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA (2009) Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer. Cancer Res 69:4708–4715CrossRefPubMed
31.
Zurück zum Zitat Mokry J, Cizkova D, Filip S, Ehrmann J, Osterreicher J, Kolar Z, English D (2004) Nestin expression by newly formed human blood vessels. Stem Cells Dev 13:658–664CrossRefPubMed Mokry J, Cizkova D, Filip S, Ehrmann J, Osterreicher J, Kolar Z, English D (2004) Nestin expression by newly formed human blood vessels. Stem Cells Dev 13:658–664CrossRefPubMed
32.
Zurück zum Zitat Klein T, Ling Z, Heimberg H, Madsen OD, Heller RS, Serup P (2003) Nestin is expressed in vascular endothelial cells in the adult human pancreas. J Histochem Cytochem 51:697–706CrossRefPubMed Klein T, Ling Z, Heimberg H, Madsen OD, Heller RS, Serup P (2003) Nestin is expressed in vascular endothelial cells in the adult human pancreas. J Histochem Cytochem 51:697–706CrossRefPubMed
33.
Zurück zum Zitat Sugawara K, Kurihara H, Negishi M, Saito N, Nakazato Y, Sasaki T, Takeuchi T (2002) Nestin as a marker for proliferative endothelium in gliomas. Lab Invest 82:345–351CrossRefPubMed Sugawara K, Kurihara H, Negishi M, Saito N, Nakazato Y, Sasaki T, Takeuchi T (2002) Nestin as a marker for proliferative endothelium in gliomas. Lab Invest 82:345–351CrossRefPubMed
34.
Zurück zum Zitat Teranishi N, Naito Z, Ishiwata T, Tanaka N, Furukawa K, Seya T, Shinji S, Tajiri T (2007) Identification of neovasculature using nestin in colorectal cancer. Int J Oncol 30:593–603PubMed Teranishi N, Naito Z, Ishiwata T, Tanaka N, Furukawa K, Seya T, Shinji S, Tajiri T (2007) Identification of neovasculature using nestin in colorectal cancer. Int J Oncol 30:593–603PubMed
35.
Zurück zum Zitat Salehi F, Kovacs K, Cusimano MD, Horvath E, Bell CD, Rotondo F, Scheithauer BW (2008) Immunohistochemical expression of nestin in adenohypophysial vessels during development of pituitary infarction. J Neurosurg 108:118–123CrossRefPubMed Salehi F, Kovacs K, Cusimano MD, Horvath E, Bell CD, Rotondo F, Scheithauer BW (2008) Immunohistochemical expression of nestin in adenohypophysial vessels during development of pituitary infarction. J Neurosurg 108:118–123CrossRefPubMed
36.
Zurück zum Zitat Chen J, Hersmus N, Van Duppen V, Caesens P, Denef C, Vankelecom H (2005) The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. Endocrinology 146:3985–3998CrossRefPubMed Chen J, Hersmus N, Van Duppen V, Caesens P, Denef C, Vankelecom H (2005) The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. Endocrinology 146:3985–3998CrossRefPubMed
37.
38.
Zurück zum Zitat Krylyshkina O, Chen J, Mebis L, Denef C, Vankelecom H (2005) Nestin-immunoreactive cells in rat pituitary are neither hormonal nor typical folliculo-stellate cells. Endocrinology 146:2376–2387CrossRefPubMed Krylyshkina O, Chen J, Mebis L, Denef C, Vankelecom H (2005) Nestin-immunoreactive cells in rat pituitary are neither hormonal nor typical folliculo-stellate cells. Endocrinology 146:2376–2387CrossRefPubMed
39.
Zurück zum Zitat Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV (2001) Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 438:595–602CrossRefPubMed Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV (2001) Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 438:595–602CrossRefPubMed
40.
Zurück zum Zitat Vidal S, Horvath E, Kovacs K, Lloyd RV, Scheithauer BW (2003) Microvascular structural entropy: a novel approach to assess angiogenesis in pituitary tumors. Endocr Pathol 14:239–247CrossRefPubMed Vidal S, Horvath E, Kovacs K, Lloyd RV, Scheithauer BW (2003) Microvascular structural entropy: a novel approach to assess angiogenesis in pituitary tumors. Endocr Pathol 14:239–247CrossRefPubMed
41.
Zurück zum Zitat Pizarro CB, Oliveira MC, Pereira-Lima JF, Leaes CG, Kramer CK, Schuch T, Barbosa-Coutinho LM, Ferreira NP (2009) Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker. Neuropathology 29:40–44CrossRefPubMed Pizarro CB, Oliveira MC, Pereira-Lima JF, Leaes CG, Kramer CK, Schuch T, Barbosa-Coutinho LM, Ferreira NP (2009) Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker. Neuropathology 29:40–44CrossRefPubMed
42.
Zurück zum Zitat Turner HE, Nagy Z, Gatter KC, Esiri MM, Wass JA, Harris AL (2000) Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour. Br J Cancer 82:1441–1445CrossRefPubMed Turner HE, Nagy Z, Gatter KC, Esiri MM, Wass JA, Harris AL (2000) Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour. Br J Cancer 82:1441–1445CrossRefPubMed
43.
Zurück zum Zitat Niveiro M, Aranda FI, Peiro G, Alenda C, Pico A (2005) Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Hum Pathol 36:1090–1095CrossRefPubMed Niveiro M, Aranda FI, Peiro G, Alenda C, Pico A (2005) Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Hum Pathol 36:1090–1095CrossRefPubMed
Metadaten
Titel
Enhanced nestin expression and small blood vessels in human pituitary adenomas
verfasst von
María Inés Perez-Millan
Silvia Inés Berner
Guillermina María Luque
Cristian De Bonis
Gustavo Sevlever
Damasia Becu-Villalobos
Carolina Cristina
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 3/2013
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-012-0421-9

Weitere Artikel der Ausgabe 3/2013

Pituitary 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.